Bank Julius Baer & Co. Ltd, Zurich
BankPosition in OGI — Organigram Global Inc.
CIK 1544599
ZURICH, V8
Position in OGI
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$10,034
-$3,006 QoQ
Shares Held
9,838
+1.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 69 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank Julius Baer & Co. Ltd, Zurich holds $50,041,551 across 9 Drug Manufacturers - Specialty & Generic names. OGI ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
4,481,615 | $41,813,467 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
23,780 | $4,007,881 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
6,050 | $3,278,071 | |
| 4 | ZTS |
Zoetis Inc.
|
10,367 | $744,972 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,236 | $109,635 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
5,000 | $72,450 | |
| 7 | OGI |
Organigram Global Inc.
This page
|
9,838 | $10,034 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
977 | $4,386 |
All Filings in OGI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,034 | 9,838 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $13,040 | 9,732 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $16,578 | 9,868 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $19,938 | 9,822 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $9,733 | 7,210 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||